Suchergebnisse - "JAK inhibitor"

PubPharm (1.803)

1

Upadacitinib-Induced Hepatitis B Reactivation Leading to Liver Transplant

enthalten in: ACG case reports journal | 2024

von Khan, S. | Zahid, R. | Amir, M.

2

Commentary on picosecond Nd:YAG laser therapy for pigmentation due to lichen planus pigmentosus in a patient with skin of color

enthalten in: JAAD case reports | 2024

von Wambier, C.

3

Complete response of actinic prurigo to oral baricitinib

enthalten in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2024

von Gil-Lianes, J. | Luque-Luna, M. | Morgado-Carrasco, D.

4

Janus kinase inhibitors and the changing landscape of vitiligo management : a scoping review

enthalten in: International journal of dermatology | 2024

von Utama, A. | Wijesinghe, R. | Thng, S.

5

Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib : A multicenter retrospective study

enthalten in: Journal of the American Academy of Dermatology | 2024

von Avallone, G. | Mastorino, L. | Tavoletti, G. | +33

6

Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients : a patient-centered survey study

enthalten in: International journal of women's dermatology | 2024

von Nohria, A. | Zhang, Y. | Desai, D. | +5

7

Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease : a case series and literature review on Janus kinase inhibitors for the disease

enthalten in: Rheumatology international | 2024

von Harada, H. | Shoda, H. | Tsuchiya, H. | +3

8

Atopic dermatitis : treatment and innovations in immunotherapy

enthalten in: Inflammopharmacology | 2024

von Ferrara, F. | Zovi, A. | Capuozzo, M. | +1

9

Recapitulating primary immunodeficiencies with expanded potential stem cells : Proof of concept with STAT1 gain of function

enthalten in: The Journal of allergy and clinical immunology | 2024

von Liu, X. | Chan, V. | Smith, K. | +8

10

Ruxolitinib Improves Immune-Dysregulation Features but not Epigenetic Abnormality in a Patient with STAT1 GOF

enthalten in: Journal of clinical immunology | 2024

von Koh, J. | Kim, D. | Son, S. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[181]